Citations

Clear

403 citation(s) found for "D'Souza, A".

Evaluating the analgesic effectiveness of erector spinae plane block for patients undergoing cardiac surgery: a systematic review and meta-analysis of randomized trials
Hussain, Nasir , Brull, Richard , D'Souza, Ryan S , Abdallah, Faraj W.

Mayo Clinic

Regional Anesthesia & Pain Medicine | November 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: rapm-2026-108247

10.1136/rapm-2026-108247 | PMID 43039646 Get It

Artificial Intelligence Models to Predict Recurrence in Patients with Differentiated Thyroid Cancer: A PROBAST + AI Systematic Review of Clinical Applicability
Solis-Pazmino, Paola , Samaniego, Alison Fernanda , Laurini de Souza Meyer, Erika , Pilatuna, Eduardo A , González-Velázquez, Camilo , Lincango, Eddy P., Figueroa, Luis A , Toro-Tobon, David

Mayo Clinic

Thyroid® | November 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/10507256261504546 | PMID 43018984 Get It

Background: Differentiated thyroid cancer (DTC) generally carries an excellent prognosis, yet recurrence occurs in up to 8–9% of patients. Artificial intelligence (AI) models are increasingly proposed to predict DTC recurrence; however, their methodological quality and clinical readiness are poorly defined. We conducted a systematic review to evaluate the methodological quality, risk of bias, and applicability of these models using the PROBAST + AI framework. Methods: We searched Ovid MEDLINE, Embase, Cochrane databases, Scopus, and Web of Science from inception to July 13, 2026. Eligible studies included original research developing or validating AI models for recurrence in DTC. Model quality (for development), risk of bias (for evaluation), and applicability were assessed using the PROBAST + AI framework, with a focus on discrimination, calibration, and validation strategies (PROSPERO; registration number [CRD420251004644]). Results: Of 673 records screened, 34 studies were included (21 unique datasets and 13 UCI-derived publications), encompassing 21,267 patients with a recurrence rate of 7.8%. Most were developed in Asian cohorts (17 of 21 datasets) and were structured clinical/tabular variables (82.4%), including demographic, clinical, laboratory, and pathological data, whereas the remaining models incorporated multimodal inputs such as imaging-derived or radiomic features. Notably, nearly one quarter of included studies (13 of 34, 38%) represented reanalysis of a single dataset. Discrimination was reported in 22 of 34 studies (64.7%) (area under the receiver operating characteristic curve [AUC] 0.67–1.00), though only 10 studies assessed calibration, none with standardized metrics. The PROBAST + AI assessment revealed high overall quality concerns in 26 of 34 (76.5%) development studies due to reliance on single-center cohorts, inadequate handling of missing data, and absence of external validation. Only 6 of 34 included studies (17.6%) were judged to have low overall quality concern, whereas 17 of 34 (50.0%) were rated as having low applicability concern. Conclusions: AI models for predicting DTC recurrence show promising discriminatory performance but have substantial methodological shortcomings in development, and a lack of calibration and external validation necessary for clinical use. Given the guidelines’ emphasis on risk-adapted de-escalation of therapy, the development of robust, validated, and clinically calibrated AI tools is a priority. Current evidence remains insufficient to support routine clinical use.
Comparison of oral and intravenous methadone for postoperative analgesia after cardiac surgery: a pilot randomized clinical trial
Ramanujan, Krishnan S. , Grate, Jeremy C. , Khan, Fazal , Paul, Johar , D'Souza, Ryan S

Mayo Clinic

Regional Anesthesia & Pain Medicine | October 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: rapm-2026-108588

10.1136/rapm-2026-108588 | PMID 42919629 Get It

Medicare and Medicaid Professional Fee Reimbursement for Spinal Cord Stimulation: An Analysis of National and State-level Trends
Mizerak, Evan J, D'Souza, Ryan S

Mayo Clinic

Pain Medicine | October 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/pm/pnag138 | PMID 42895296 Get It

Abstract Background Spinal cord stimulation (SCS) is an important modality for treating chronic pain in patients who have failed conservative therapy and a substantial portion of the population rely on fee-for-service Medicare or Medicaid for coverage. We aimed to determine physician professional fee reimbursement rates and the ratio of Medicaid to Medicare professional fee reimbursement (MMI) for three common Current Procedural Terminology (CPT) codes related to SCS therapy (63650, 63685, and 63655) across states. Secondarily, we explored trends in utilization and reimbursement of these procedures by Medicare at the national level between 2013 and 2023. Methods Medicaid professional fee reimbursement data were extracted from publicly available fee schedules where available for individual states, while Medicare reimbursement data were extracted from the Centers for Medicare and Medicaid Services (CMS) Physician Fee Schedule. Baseline and wage-adjusted MMI values were calculated for each state. Results Medicaid reimbursed 11.5–21.0% less than Medicare across the evaluated CPT codes after wage adjustment, with differences of 11.8% for CPT 63650 (facility), 18.0% for CPT 63650 (non-facility), 11.5% for CPT 63685 (facility), and 21.0% for CPT 63655 (facility). Medicaid MMI values ranged from 0.397–1.87 across codes and settings. State-level Medicaid professional fee reimbursement varied substantially, ranging from $194.52–$639.38 for CPT 63650 (facility), $978.72–$2,781.65 for CPT 63650 (non-facility), $160.82–$558.00 for CPT 63685 (facility), and $375.97–$1,045.15 for CPT 63655 (facility); Medicare reimbursement was substantially less variable. From 2013–2023, Medicare utilization, rendering providers, beneficiaries, and standardized payments generally increased, although trends varied by CPT code and site of service. Conclusions Medicare physician professional fee reimbursement largely exceeds Medicaid physician professional fee reimbursement for three of the most common SCS procedural codes, suggesting potential access barriers to chronic pain procedures. Medicaid reimbursement shows considerable variation across states and among procedural codes, suggesting substantial interstate heterogeneity in Medicaid rate-setting that may reflect differences in state policy priorities or other factors not analyzed in this study.
Colony‐stimulating factor 1 receptor‐related disorder: Clinical variability of biallelic variants
Milanowski, Łukasz , Santos, Mara Lucia Schmitz Ferreira , Teive, Helio G., Fink, John K., Orthmann‐Murphy, Jennifer, Arnold, Kaley, Wszołek, Zbigniew K. , Wszolek, Z.K. , Milanowski, Łukasz M , Souza, Josiane , Teive, Hélio Afonso Ghizoni , Fink, John K. , Orthmann‐Murphy, Jennifer , Dulski, Jarosław , Group, CSF1R‐RD Study

Mayo Clinic

Developmental Medicine & Child Neurology | September 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/dmcn.70515 | PMID 42706750 Get It

Abstract Biallelic colony‐stimulating factor 1 receptor ( CSF1R ) variants are a major cause of early‐onset CSF1R ‐related disorder (CSF1R‐RD), although fewer than 30 cases have been reported and genotype–phenotype correlations remain unclear. The aim of this study was to characterize the clinical, radiological, and genetic features of patients with brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS). Six patients with biallelic CSF1R variants underwent detailed clinical, neurological, and magnetic resonance imaging evaluation. Three siblings with a homozygous p.Gly585Val variant showed marked phenotypic variability, ranging from severe childhood‐onset neurodegeneration to an asymptomatic presentation, all with white matter abnormalities. Three unrelated patients carried different biallelic CSF1R variants and presented with congenital skeletal abnormalities or early‐onset neurological disease of variable severity. These cases broaden the phenotypic spectrum of biallelic CSF1R‐RD and demonstrate that disease severity cannot be predicted solely by genotype, suggesting an important role for genetic or environmental modifiers.
Outcome‐framework adherence in neuromodulation studies for chronic pain: evidence from a systematic gap map
Goudman, Lisa , Vollert, Jan, D'Souza, Ryan, Moens, Maarten , Forget, Patrice , D'Souza, Ryan S , Vollert, Jan

Mayo Clinic

Anaesthesia | July 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/anae.70301 | PMID 42478268 Get It

Venous Sinus Stenting for Pulsatile Tinnitus: A Systematic Review and Meta-Analysis
Khabir, Sevda Alipour , Ognard, Julien, Souza, Natália Vasconcellos de Oliveira , Heidtke, Owen, Lindell, Tor, Bayraktar, Esref, Bilgin, C, Ghozy, S, Kadirvel, R, Kallmes, David F., Brinjikji, Waleed , Alipour Khabir, Sevda , El Hajj, Gerard , de Oliveira Souza, Natália Vasconcellos , Ognard, Julien , Hajj, G El , Bayraktar, Esref Alperen , Ghozy, Sherief , Kadirvel, Ramanathan , Kallmes, David F.

Mayo Clinic

Otology & Neurotology | July 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/mao.0000000000005016 | PMID 42476523 Get It

Background: Pulsatile tinnitus (PT) is frequently caused by venous sinus stenosis and may be associated with idiopathic intracranial hypertension (IIH). Venous sinus stenting (VSS) directly addresses venous outflow obstruction and has emerged as a therapeutic option; however, outcome data remain heterogeneous. We performed an updated systematic review and meta-analysis to evaluate the efficacy and durability of VSS for PT and to compare outcomes between IIH-associated and isolated PT. Methods: MEDLINE, Scopus, and Web of Science were searched from inception through December 2025 following PRISMA guidelines. Clinical studies reporting PT outcomes after VSS were included. Random-effects meta-analyses of proportions were conducted to estimate pooled rates of overall improvement, complete resolution, and recurrence. Prespecified subgroup analyses compared IIH versus isolated PT. Results: Thirty-two studies comprising 850 patients were included (641 with IIH; 209 with isolated PT). Venous sinus stenosis accounted for 90.3% of treated etiologies. The pooled rate of overall PT improvement was 89.8% (95% CI, 85.5-92.9). Complete resolution occurred in 87.1% (95% CI, 82.5-90.6). Recurrence at last follow-up was 10.9% (95% CI, 8.3-14.2). Improvement and complete resolution rates did not differ significantly between IIH and isolated PT. Recurrence was higher in IIH (12.0%) than in isolated PT (5.7%), without reaching statistical significance. Conclusions: VSS is associated with high rates of PT improvement and complete resolution with low recurrence. Recurrence trends appear higher in IIH, suggesting underlying pathophysiology may influence durability.
E-100 Reducing inequalities in stroke events-hemorrhagic disparities (RISE-HD): a 10-year statewide analysis of social determinants of mortality in hemorrhagic stroke
Souza, N de Oliveira, Diíaz-Rohena, A, Sakusic, A, Galbert, L, Borkar, S, Spaulding, A, Mooney, LH, Robinson, MT, Freeman, W, Sakusic, Amra , Galbert, Liyah, Borkar, Shalmali R. , Robinson, MT, Freeman, W. David

Mayo Clinic

SNIS 23rd Annual Meeting Electronic Poster Abstracts | July 20, 2026 | Volume: No volume available | Issue: No issue available | Pages: A153.1-A153

10.1136/jnis-2026-snis.204 Get It

O-024 Comparative effectiveness of embolic agents in middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis
Souza, N Vasconcellos de Oliveira, Hamouda, A, Abdallah, A Khalid, Seifuldin, M, Atieh, F, Hamdy, R, Hossameldin, S, Ghozy, S, Brinjikji, W, Kadrivel, R, Kallmes, D, Jabbour, P, Souza, Natália Vasconcellos de Oliveira , Hamouda, A, Abdallah, Amr Khalid, Seifuldin, Mohammed, Atieh, Fatima , Hossameldin, Saifeldin , Ghozy, Sherief , Kadrivel, Ram, Kallmes, David F. , Jabbour, Pascal

Mayo Clinic

SNIS 23rd Annual Meeting Oral Abstracts | July 20, 2026 | Volume: No volume available | Issue: No issue available | Pages: A21-A22

10.1136/jnis-2026-snis.24 Get It